Pharmaceuticals have been on the tabloids lately due in part for infamous company price gouging but today 3 firms are uniting to make their contributions by analyze data of healthy adult volunteers. By studying health data patients, it can used to compare/contrast other patient stratification in with a global footprint and perhaps accelerate innovation of other drugs and discovery. Though the initial focus on therapeutic areas, the power of big data and analytics is contagious. The 3 biomakers are Astellas, Daiichi Sankyo, and Takeda.
Article Source: The Financial
No comments:
Post a Comment